According to the widely accepted" three Es" model, the host immune system eliminates malignant cell precursors and contains microscopic neoplasms in a dynamic equilibrium …
L Ning, W Wei, J Wenyang, X Rui… - Clinical and …, 2020 - Wiley Online Library
The role of NOD‐like receptor protein 3 (NLRP3)‐mediated pyroptosis in acute lung injury (ALI) has been well identified previously. Stimulator of interferon genes (STING) is an …
Arginine methylation is an influential post-translational modification occurring on histones, RNA binding proteins, and many other cellular proteins, affecting their function by altering …
J Liu, X Bu, C Chu, X Dai, JM Asara, P Sicinski… - Nature …, 2023 - nature.com
Activation of the cGAS/STING innate immunity pathway is essential and effective for anti- tumor immunotherapy. However, it remains largely elusive how tumor-intrinsic cGAS …
H Kim, AR Ze'ev - Cell stress, 2020 - ncbi.nlm.nih.gov
Protein methyl transferases play critical roles in numerous regulatory pathways that underlie cancer development, progression and therapy-response. Here we discuss the function of …
J Zheng, B Li, Y Wu, X Wu, Y Wang - Journal of Medicinal …, 2023 - ACS Publications
As a predominant type II protein arginine methyltransferase, PRMT5 plays critical roles in various normal cellular processes by catalyzing the mono-and symmetrical dimethylation of …
Y Zhu, T Xia, DQ Chen, X Xiong, L Shi, Y Zuo… - Drug Resistance …, 2024 - Elsevier
Drug resistance remains a major challenge in cancer treatment, necessitating the development of novel strategies to overcome it. Protein arginine methyltransferases …
M Redondo-Muñoz, FJ Rodriguez-Baena, P Aldaz… - Nature …, 2023 - nature.com
Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF …
K Feustel, GS Falchook - Journal of Immunotherapy and …, 2022 - meridian.allenpress.com
ABSTRACT Protein arginine methyltransferase 5 (PRMT5) inhibitors are a new class of antineoplastic agents showing promising preliminary clinical efficacy. Targeting an enzyme …